<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03065647</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00117553</org_study_id>
    <secondary_id>R34HL130738-01A1</secondary_id>
    <nct_id>NCT03065647</nct_id>
  </id_info>
  <brief_title>ECPR for Refractory Out-Of-Hospital Cardiac Arrest</brief_title>
  <acronym>EROCA</acronym>
  <official_title>Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest (EROCA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Food and Drug Administration (FDA)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Physio-Control</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the U.S. alone, over 300,000 people per year have sudden out-of-hospital cardiac arrest&#xD;
      (OHCA), and less than 1 out of 10 survive. The current standard practice for treating OHCA is&#xD;
      to perform cardiopulmonary resuscitation (CPR) and Advanced Cardiovascular Life Support&#xD;
      (ACLS) at the scene until either the heart is restarted or resuscitation efforts are&#xD;
      considered hopeless and discontinued. An alternative strategy for those with refractory OHCA&#xD;
      is expedited transport with ongoing mechanical CPR to an Emergency Department capable of&#xD;
      performing extracorporeal cardiopulmonary resuscitation (ECPR). The purpose of study is to&#xD;
      test if this strategy is feasible and beneficial.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Out-of-hospital sudden cardiac arrest (OHCA) is a life-threatening condition in which the&#xD;
      heart suddenly stops beating and there is no blood flow to the body. If cardiac arrest is not&#xD;
      treated immediately, it causes sudden death. In the U.S. alone, over 300,000 people per year&#xD;
      have OHCA, and less than 1 out of 10 survive. Therefore, it is important to study new ways of&#xD;
      treating cardiac arrest patients in order to improve survival.&#xD;
&#xD;
      The current standard practice for treating OHCA is to perform CPR and Advanced Cardiovascular&#xD;
      Life Support (ACLS) at the scene until either the heart is restarted or resuscitation efforts&#xD;
      are considered hopeless and discontinued. This practice is supported by the fact that all&#xD;
      currently proven CPR therapies can be delivered by paramedics in the field.&#xD;
&#xD;
      However, promising new strategies have emerged that are more feasible to initiate in the&#xD;
      hospital. One such strategy is extracorporeal cardiopulmonary resuscitation (ECPR). ECPR&#xD;
      requires placement of catheters in large blood vessels and connected to a machine to take&#xD;
      over the work of the heart and lungs.&#xD;
&#xD;
      This purpose of this study is to examine the feasibility and potential benefit of expedited&#xD;
      transport with ongoing mechanical CPR for patients with refractory OHCA patients to an&#xD;
      Emergency Department capable of initiating ECPR.&#xD;
&#xD;
      FDA approved this study as a staged feasibility study to enroll 15 participants and submit&#xD;
      data prior to enrolling the second 15 participants. After enrolling 15 participants, the PI&#xD;
      chose not to pursue an amendment to enroll additional participants due to slow accrual and&#xD;
      research restrictions related to COVID.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Actual">March 5, 2020</completion_date>
  <primary_completion_date type="Actual">March 5, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Emergency Department Arrivals Under 30 Minutes</measure>
    <time_frame>Measured within one hour cardiac arrest onset</time_frame>
    <description>Proportion of patients with emergency department (ED) arrival less than or equal to 30 minutes from 911 call (or cardiac arrest onset if witnessed by EMS personnel).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ECPR Initiations Under 30 Minutes</measure>
    <time_frame>Measured within 2 hours of cardiac arrest onset</time_frame>
    <description>Proportion of ECPR eligible patients with ECPR flow initiated less than or equal to 30 minutes from ED arrival</description>
  </primary_outcome>
  <other_outcome>
    <measure>Functional Neurological Outcome: CPC</measure>
    <time_frame>At time of hospital discharge (an average of 7 days) and 90 days after cardiac arrest</time_frame>
    <description>Cerebral Performance Category score is widely used in cardiac arrest research to assess neurologic outcome</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional Neurological Outcome: mRS</measure>
    <time_frame>At time of hospital discharge (an average of 7 days) and 90 days after cardiac arrest</time_frame>
    <description>modified Rankin Score commonly used for measuring the degree of disability or dependence in the daily activities of people who have suffered a neurological disability.</description>
  </other_outcome>
  <other_outcome>
    <measure>Neuropsychological Outcome Battery: NIH Toolbox</measure>
    <time_frame>At time of hospital discharge (an average of 7 days) and 90 days after cardiac arrest</time_frame>
    <description>The NIH toolbox includes cognitive testing and can be administered using an iPad</description>
  </other_outcome>
  <other_outcome>
    <measure>Neuro Quality of Life: Neuro QoL</measure>
    <time_frame>90 days after cardiac arrest</time_frame>
    <description>Quality of Life in Neurological Disorders is a measurement system that evaluates and monitors the physical, mental, and social effects experienced by adults living with neurological conditions.</description>
  </other_outcome>
  <other_outcome>
    <measure>Safety: Composite Prevalence of 6 Specified Adverse Events</measure>
    <time_frame>At time of hospital discharge (an average of 7 days) and 90 days after cardiac arrest</time_frame>
    <description>Composite safety endpoint of hemorrhage requiring blood transfusion, vessel damage requiring vascular procedure or leading to occlusion, venous/arterial thromboembolism, stroke, renal failure, and infection.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Cardiac Arrest</condition>
  <condition>Heart Arrest</condition>
  <condition>Sudden Cardiac Arrest</condition>
  <condition>Cardiopulmonary Arrest</condition>
  <condition>Death, Sudden, Cardiac</condition>
  <condition>Cardiopulmonary Resuscitation</condition>
  <condition>CPR</condition>
  <condition>Extracorporeal Cardiopulmonary Resuscitation</condition>
  <condition>Extracorporeal Membrane Oxygenation</condition>
  <arm_group>
    <arm_group_label>Standard Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS) by Emergency Medical Services (EMS) per existing EMS protocols at the scene of the cardiac arrest.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Expedited Transport</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: Expedited Transport with Mechanical CPR.&#xD;
After initial Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS) by Emergency Medical Services (EMS) per existing EMS protocols, patients with refractory cardiac arrest are transported to an ECPR capable emergency department with ongoing mechanical CPR and ACLS for possible initiation of extracorporeal cardiopulmonary resuscitation (ECPR).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Expedited Transport With Mechanical CPR</intervention_name>
    <description>Patients with OHCA refractory to initial BLS and ACLS will be transported by EMS with ongoing mechanical CPR and ACLS to an emergency department capable of initiating ECPR.</description>
    <arm_group_label>Expedited Transport</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  OHCA of presumed non-traumatic etiology requiring CPR&#xD;
&#xD;
          -  Predicted arrival time at ECPR-capable hospital within timeframe specified&#xD;
&#xD;
          -  Witnessed arrest or initial shockable rhythm (VT or VF)&#xD;
&#xD;
          -  Persistent cardiac arrest after initial cardiac rhythm analysis and shock (if shock is&#xD;
             indicated)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Sustained return of spontaneous circulation (ROSC)&#xD;
&#xD;
          -  Advanced directive indicating do not attempt resuscitation (DNAR) or do not intubate&#xD;
             (DNI)&#xD;
&#xD;
          -  Preexisting evidence of opting out of study&#xD;
&#xD;
          -  Prisoner&#xD;
&#xD;
          -  Pregnant (obvious or known)&#xD;
&#xD;
          -  ECPR capable ED is not at the destination hospital as determined by EMS&#xD;
&#xD;
          -  Legally authorized representative (LAR) or family member aware of study and refuses&#xD;
             study participation at the scene&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert W Neumar, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert H Bartlett, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.medicine.umich.edu/dept/emergency-medicine/eroca-study</url>
    <description>EROCA Study Website</description>
  </link>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 16, 2017</study_first_submitted>
  <study_first_submitted_qc>February 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2017</study_first_posted>
  <results_first_submitted>February 19, 2021</results_first_submitted>
  <results_first_submitted_qc>February 19, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 15, 2021</results_first_posted>
  <last_update_submitted>May 10, 2021</last_update_submitted>
  <last_update_submitted_qc>May 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Robert Neumar</investigator_full_name>
    <investigator_title>Professor and Chair, Department of Emergency Medicine</investigator_title>
  </responsible_party>
  <keyword>Out-of-hospital cardiac arrest</keyword>
  <keyword>Cardiac Arrest</keyword>
  <keyword>Heart Arrest</keyword>
  <keyword>Sudden Cardiac Arrest</keyword>
  <keyword>Cardiopulmonary Resuscitation</keyword>
  <keyword>Extracorporeal Cardiopulmonary Resuscitation</keyword>
  <keyword>Extracorporeal Membrane Oxygenation</keyword>
  <keyword>CPR</keyword>
  <keyword>ECPR</keyword>
  <keyword>ECMO</keyword>
  <keyword>Emergency Medical Services</keyword>
  <keyword>EMS</keyword>
  <keyword>OHCA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Death, Sudden</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 15, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/47/NCT03065647/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard Care</title>
          <description>Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS) by Emergency Medical Services (EMS) per existing EMS protocols at the scene of the cardiac arrest.</description>
        </group>
        <group group_id="P2">
          <title>Expedited Transport</title>
          <description>Intervention: Expedited Transport with Mechanical CPR.&#xD;
After initial Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS) by Emergency Medical Services (EMS) per existing EMS protocols, patients with refractory cardiac arrest are transported to an ECPR capable emergency department with ongoing mechanical CPR and ACLS for possible initiation of extracorporeal cardiopulmonary resuscitation (ECPR).&#xD;
Expedited Transport With Mechanical CPR: Patients with OHCA refractory to initial BLS and ACLS will be transported by EMS with ongoing mechanical CPR and ACLS to an emergency department capable of initiating ECPR.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Care</title>
          <description>Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS) by Emergency Medical Services (EMS) per existing EMS protocols at the scene of the cardiac arrest.</description>
        </group>
        <group group_id="B2">
          <title>Expedited Transport</title>
          <description>Intervention: Expedited Transport with Mechanical CPR.&#xD;
After initial Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS) by Emergency Medical Services (EMS) per existing EMS protocols, patients with refractory cardiac arrest are transported to an ECPR capable emergency department with ongoing mechanical CPR and ACLS for possible initiation of extracorporeal cardiopulmonary resuscitation (ECPR).&#xD;
Expedited Transport With Mechanical CPR: Patients with OHCA refractory to initial BLS and ACLS will be transported by EMS with ongoing mechanical CPR and ACLS to an emergency department capable of initiating ECPR.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="15"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61" spread="3"/>
                    <measurement group_id="B2" value="62" spread="8"/>
                    <measurement group_id="B3" value="62" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Initial cardiac rythm</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Ventricular fibrilation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Witnessed pulseless electrical activity (PEA)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Witnessed asystole</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Bystander CPR</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cardiac Arrest Locaion</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Home</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Public Location</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Emergency Department Arrivals Under 30 Minutes</title>
        <description>Proportion of patients with emergency department (ED) arrival less than or equal to 30 minutes from 911 call (or cardiac arrest onset if witnessed by EMS personnel).</description>
        <time_frame>Measured within one hour cardiac arrest onset</time_frame>
        <population>Standard care participants received EMS protocols at the scene, and thus were not included in this analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS) by Emergency Medical Services (EMS) per existing EMS protocols at the scene of the cardiac arrest.</description>
          </group>
          <group group_id="O2">
            <title>Expedited Transport</title>
            <description>Intervention: Expedited Transport with Mechanical CPR.&#xD;
After initial Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS) by Emergency Medical Services (EMS) per existing EMS protocols, patients with refractory cardiac arrest are transported to an ECPR capable emergency department with ongoing mechanical CPR and ACLS for possible initiation of extracorporeal cardiopulmonary resuscitation (ECPR).&#xD;
Expedited Transport With Mechanical CPR: Patients with OHCA refractory to initial BLS and ACLS will be transported by EMS with ongoing mechanical CPR and ACLS to an emergency department capable of initiating ECPR.</description>
          </group>
        </group_list>
        <measure>
          <title>Emergency Department Arrivals Under 30 Minutes</title>
          <description>Proportion of patients with emergency department (ED) arrival less than or equal to 30 minutes from 911 call (or cardiac arrest onset if witnessed by EMS personnel).</description>
          <population>Standard care participants received EMS protocols at the scene, and thus were not included in this analysis</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>ECPR Initiations Under 30 Minutes</title>
        <description>Proportion of ECPR eligible patients with ECPR flow initiated less than or equal to 30 minutes from ED arrival</description>
        <time_frame>Measured within 2 hours of cardiac arrest onset</time_frame>
        <population>Analysis includes participants eligible for ECPR.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard Care</title>
            <description>Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS) by Emergency Medical Services (EMS) per existing EMS protocols at the scene of the cardiac arrest.</description>
          </group>
          <group group_id="O2">
            <title>Expedited Transport</title>
            <description>Intervention: Expedited Transport with Mechanical CPR.&#xD;
After initial Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS) by Emergency Medical Services (EMS) per existing EMS protocols, patients with refractory cardiac arrest are transported to an ECPR capable emergency department with ongoing mechanical CPR and ACLS for possible initiation of extracorporeal cardiopulmonary resuscitation (ECPR).&#xD;
Expedited Transport With Mechanical CPR: Patients with OHCA refractory to initial BLS and ACLS will be transported by EMS with ongoing mechanical CPR and ACLS to an emergency department capable of initiating ECPR.</description>
          </group>
        </group_list>
        <measure>
          <title>ECPR Initiations Under 30 Minutes</title>
          <description>Proportion of ECPR eligible patients with ECPR flow initiated less than or equal to 30 minutes from ED arrival</description>
          <population>Analysis includes participants eligible for ECPR.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Functional Neurological Outcome: CPC</title>
        <description>Cerebral Performance Category score is widely used in cardiac arrest research to assess neurologic outcome</description>
        <time_frame>At time of hospital discharge (an average of 7 days) and 90 days after cardiac arrest</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Functional Neurological Outcome: mRS</title>
        <description>modified Rankin Score commonly used for measuring the degree of disability or dependence in the daily activities of people who have suffered a neurological disability.</description>
        <time_frame>At time of hospital discharge (an average of 7 days) and 90 days after cardiac arrest</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Neuropsychological Outcome Battery: NIH Toolbox</title>
        <description>The NIH toolbox includes cognitive testing and can be administered using an iPad</description>
        <time_frame>At time of hospital discharge (an average of 7 days) and 90 days after cardiac arrest</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Neuro Quality of Life: Neuro QoL</title>
        <description>Quality of Life in Neurological Disorders is a measurement system that evaluates and monitors the physical, mental, and social effects experienced by adults living with neurological conditions.</description>
        <time_frame>90 days after cardiac arrest</time_frame>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Safety: Composite Prevalence of 6 Specified Adverse Events</title>
        <description>Composite safety endpoint of hemorrhage requiring blood transfusion, vessel damage requiring vascular procedure or leading to occlusion, venous/arterial thromboembolism, stroke, renal failure, and infection.</description>
        <time_frame>At time of hospital discharge (an average of 7 days) and 90 days after cardiac arrest</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Participants were followed for 90 days after intervention</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Standard Care</title>
          <description>Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS) by Emergency Medical Services (EMS) per existing EMS protocols at the scene of the cardiac arrest.</description>
        </group>
        <group group_id="E2">
          <title>Expedited Transport</title>
          <description>Intervention: Expedited Transport with Mechanical CPR.&#xD;
After initial Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS) by Emergency Medical Services (EMS) per existing EMS protocols, patients with refractory cardiac arrest are transported to an ECPR capable emergency department with ongoing mechanical CPR and ACLS for possible initiation of extracorporeal cardiopulmonary resuscitation (ECPR).&#xD;
Expedited Transport With Mechanical CPR: Patients with OHCA refractory to initial BLS and ACLS will be transported by EMS with ongoing mechanical CPR and ACLS to an emergency department capable of initiating ECPR.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Hemorrhagic Shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Failure to establish circuit blood flow</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Ventricular Fibrillation/Ventricular Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Cardiogenic Shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Non ST Elevation Myocardial Infarction (NSTEMI)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Hemopericardium</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Liver Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Tracheal aspirate - Methicillin-sensitive Staphylococcus aureus (MSSA)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Hemoperitoneum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Anoxic brain injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Ischemic Stroke</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Kidney Injury (AKI)</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Presumed Moderate Acute Respiratory Distress Syndrome (ARDS)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Ischemic Skin Necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Hemorrhage from cannulation site</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Robert Neumar</name_or_title>
      <organization>University of Michigan</organization>
      <phone>734-936-0253</phone>
      <email>neumar@umich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

